中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Design, Syntheses and Anticancer Activities of Platinum(IV) Prodrugs with Dihydrogen Phosphate as an Axial Ligand

文献类型:期刊论文

作者Gao An-Li1; Xiong Qing-Feng1; Jiang Jing1; Yu Juan1; Lou Li-Guang2; Liu Wei-Ping1
刊名CHINESE JOURNAL OF INORGANIC CHEMISTRY
出版日期2018-09-10
卷号34期号:9页码:1649-1654
关键词platinum(IV) complexes synthesis characterization anticancer activity
ISSN号1001-4861
DOI10.11862/CJIC.2018.211
文献子类Article
英文摘要CPL-1501 and CPL-1504, two platinum(IV) prodrugs with dihydrogen phosphate as one axial ligand, were synthesized from cisplatin and oxaliplatin, respectively, as the starting material, and characterized by elemental analysis, IR as well as C-13 and P-31 NMR. Their reduction potential was measured via the cyclic voltammetry. The standard MTT was used to evaluate anticancer activity of the two prodrugs against several human cancer cell lines. CPL-1501 has a good water-solubility (10 mg.mL(-1)) and water-stability. With the favorable E-p values, it can be readily reduced to an active prototype cisplatin in the oxygen-deprived micro-environment of cancer cells. The biological tests reveal that CPL-1501 is able to inhibit the growth of cancer cells and its anticancer activity is comparable to that of cisplatin but much greater than that of carboplatin, whereas CPL-1504 does not show significant activity, probably due to its lower E-p values.
WOS关键词COMPLEXES ; DELIVERY ; THERAPY ; AGENTS ; DRUGS ; HEPTAPLATIN ; CISPLATIN ; REDUCTION
WOS研究方向Chemistry
语种中文
CSCD记录号CSCD:6323811
WOS记录号WOS:000446645600008
出版者CHINESE CHEMICAL SOC
源URL[http://119.78.100.183/handle/2S10ELR8/279581]  
专题药理学第一研究室
通讯作者Jiang Jing; Liu Wei-Ping
作者单位1.Kunming Inst Precious Met, Platinum Based Drug Lab, Kunming 650106, Yunnan, Peoples R China;
2.Chinese Acad Sci, Shanghai Inst Mat Med, Tumor Pharmacol Lab, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Gao An-Li,Xiong Qing-Feng,Jiang Jing,et al. Design, Syntheses and Anticancer Activities of Platinum(IV) Prodrugs with Dihydrogen Phosphate as an Axial Ligand[J]. CHINESE JOURNAL OF INORGANIC CHEMISTRY,2018,34(9):1649-1654.
APA Gao An-Li,Xiong Qing-Feng,Jiang Jing,Yu Juan,Lou Li-Guang,&Liu Wei-Ping.(2018).Design, Syntheses and Anticancer Activities of Platinum(IV) Prodrugs with Dihydrogen Phosphate as an Axial Ligand.CHINESE JOURNAL OF INORGANIC CHEMISTRY,34(9),1649-1654.
MLA Gao An-Li,et al."Design, Syntheses and Anticancer Activities of Platinum(IV) Prodrugs with Dihydrogen Phosphate as an Axial Ligand".CHINESE JOURNAL OF INORGANIC CHEMISTRY 34.9(2018):1649-1654.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。